Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona Simpson

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
Current Treatment Options in Oncology|January 25, 2024
Steroid Premedication and Monoclonal Antibody Therapy: Should We Reconsider?Emma-Anne Karlsen, Euan Walpole, Fiona Simpson
Trials|February 25, 2010
A systematic review of techniques and interventions for improving adherence to inclusion and exclusion criteria during enrolment into randomised controlled trialsFiona Simpson, Elizabeth A Sweetman, Gordon S Doig
Clinicoeconomics and Outcomes Research : CEOR|September 5, 2013
Early enteral nutrition in critical illness: a full economic analysis using US costsGordon S Doig, Hélène Chevrou-Séverac, Fiona Simpson
The Australasian Journal of Dermatology|February 22, 2013
The epidermal growth factor receptor in squamous cell carcinoma: An emerging drug targetDaniel C Gaffney, H Peter Soyer, Fiona Simpson
Current Opinion in Clinical Nutrition and Metabolic Care|February 10, 2009
Evidence-based nutrition support in the intensive care unit: an update on reported trial qualityGordon S Doig, Fiona Simpson, Elizabeth A Sweetman
Cancers|November 19, 2020
Will Next-Generation Immunotherapy Overcome the Intrinsic Diversity and Low Immunogenicity of Sarcomas to Improve Clinical Benefit?Hui Yi Chew, Victor Chan, Fiona Simpson, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|February 18, 2021
Adenoid cystic carcinoma: a review of clinical features, treatment targets and advances in improving the immune response to monoclonal antibody therapyJames Nightingale, Benedict Lum, Rahul Ladwa, et al.
Methods in Enzymology|February 14, 2006
Characterization of Rab23, a negative regulator of sonic hedgehog signalingTimothy M Evans, Fiona Simpson, Robert G Parton, et al.
Current Treatment Options in Oncology|February 5, 2020
Epidermal Growth Factor Receptor's Function in Cutaneous Squamous Cell Carcinoma and Its Role as a Therapeutic Target in the Age of ImmunotherapiesPriscila Oliveira de Lima, Shannon Joseph, Benedict Panizza, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 10, 2024
A PEGylated liposomal formulation of prochlorperazine that limits brain exposure but retains dynamin II activity: A potential adjuvant therapy for cancer patients receiving chemotherapeutic mAbsChristopher N Subasic, Fiona Simpson, Rodney F Minchin, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Current Treatment Options in Oncology|January 25, 2024
Steroid Premedication and Monoclonal Antibody Therapy: Should We Reconsider?Emma-Anne Karlsen, Euan Walpole, Fiona Simpson
Trials|February 25, 2010
A systematic review of techniques and interventions for improving adherence to inclusion and exclusion criteria during enrolment into randomised controlled trialsFiona Simpson, Elizabeth A Sweetman, Gordon S Doig
Clinicoeconomics and Outcomes Research : CEOR|September 5, 2013
Early enteral nutrition in critical illness: a full economic analysis using US costsGordon S Doig, Hélène Chevrou-Séverac, Fiona Simpson
The Australasian Journal of Dermatology|February 22, 2013
The epidermal growth factor receptor in squamous cell carcinoma: An emerging drug targetDaniel C Gaffney, H Peter Soyer, Fiona Simpson
Current Opinion in Clinical Nutrition and Metabolic Care|February 10, 2009
Evidence-based nutrition support in the intensive care unit: an update on reported trial qualityGordon S Doig, Fiona Simpson, Elizabeth A Sweetman
Cancers|November 19, 2020
Will Next-Generation Immunotherapy Overcome the Intrinsic Diversity and Low Immunogenicity of Sarcomas to Improve Clinical Benefit?Hui Yi Chew, Victor Chan, Fiona Simpson, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|February 18, 2021
Adenoid cystic carcinoma: a review of clinical features, treatment targets and advances in improving the immune response to monoclonal antibody therapyJames Nightingale, Benedict Lum, Rahul Ladwa, et al.
Methods in Enzymology|February 14, 2006
Characterization of Rab23, a negative regulator of sonic hedgehog signalingTimothy M Evans, Fiona Simpson, Robert G Parton, et al.
Current Treatment Options in Oncology|February 5, 2020
Epidermal Growth Factor Receptor's Function in Cutaneous Squamous Cell Carcinoma and Its Role as a Therapeutic Target in the Age of ImmunotherapiesPriscila Oliveira de Lima, Shannon Joseph, Benedict Panizza, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 10, 2024
A PEGylated liposomal formulation of prochlorperazine that limits brain exposure but retains dynamin II activity: A potential adjuvant therapy for cancer patients receiving chemotherapeutic mAbsChristopher N Subasic, Fiona Simpson, Rodney F Minchin, et al.
Pageof 9